MD. Julio C. Fernandes¹*, MD. Pierre Ranger¹ Luis Fernando Jordao Dos Santos²

¹Université de Montreal/CIUSS du NIM, Hôpital du Sacre Coeur de Montreal, Montreal, QC, Canada
²Medical Assistant, Knee Surgeon at Trauma Center Serviços Medico Hospitalares, Brazil

*Corresponding Author:MD. Julio C. Fernandes, Université de Montreal/CIUSS du NIM, Hôpital du Sacre Coeur de Montreal, Montreal, QC, Canada.

Received: October 12, 2022; Published: November 11, 2022

Abstract

Background: Isolated patellofemoral arthritis represents around 15 to 20% of all patients with knee pain. Patellofemoral Arthroplasty has become an interesting option for severe patellofemoral joint arthritis because of the good results obtained with new implants designs.

Methods: This retrospective study has revised 117 medical records of patients submitted to patellofemoral joint arthroplasty between 2007 and 2017 at Sacre Coeur and Jean Talon Hospitals in Montreal - QC, Canada.

Results: The study has shown patellofemoral arthrosis in 52,9% of cases, followed by trochlear dysplasia (41,8%) and these are the most important factor to guide patients to surgery specially in young women (2,3:1/F:M) around fifties (50,3 yo average). Patellofemoral arthroplasty is preceded by another surgical treatment in 24,6% of cases. Patellar malalignment is present in 86,3% of patients divided in lateral displacement (24,7%), tilt patellar lateral (41,1%) and patellar height (20,5%). Patellar overstuffing is the most frequent early complication observed in 12,8% of patients. Other clinical complications had the same rate for TKA and UKA.

Conclusion: Patellofemoral Arthroplasty is a less aggressive option to treat isolated PF Arthrosis presenting the same rates of Total Knee Arthroplasty. Patellar alignment should be evaluated preoperatively and reestablished to reach good results.

Keywords: Patellofemoral Arthroplasty; Demographic; Radiological; Better Results

References

1. Van der List JP., et al. “Why do patellofemoral arthroplasties fail today? A systematic review”. Knee1 (2017): 2-8.
2. Leadbetter WB., et al. “The appropriate use of patellofemoral arthroplasty: an analysis of reported indications, contraindications, and failures”. Clinical Orthopaedics and Related Research 436 (2005): 91-99.
3. Leadbetter WB., et al. “Indications, contraindications, and pitfalls of patellofemoral arthroplasty”. Journal of Bone and Joint Surgery 88.4 (2006): 122-137.
4. Lonner JH and Bloomfield MR. “The clinical outcome of patellofemoral arthroplasty”. Orthopedic Clinics of North America 3 (2013): 271-280.
5. Pisanu G., et al. “Patellofemoral Arthroplasty: Current Concepts and Review of the Literature”. Joints 4 (2017): 237-245.
6.  Farr J 2^nd and Barrett D. “Optimizing patellofemoral arthroplasty”. Knee 5 (2008): 339-347.
7. Walker T., et al. “Patellofemoral arthroplasty: the other unicompartmental knee replacement”. Instructional Course Lectures 62 (2013): 363-371.
8. Quinn RH., et al. “Surgical Management ofOsteoarthritis of the Knee”. Journal of the American Academy of Orthopaedic Surgeons 26.9 (2018): e191-e193.
9. Senay A., et al. “Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada”. Vascular Health and Risk Management 14 (2018): 81-89.
10. El Beheiry H., et al. “Tranexamic acid administration to older patients undergoing primary total hip arthroplasty conserves hemoglobin and reduces blood loss”. Canadian Journal of Surgery 61.3 (2018): 177-184.
11. Lustig S., et al. “Patellofemoral arthroplasty, where are we today?” Knee Surgery, Sports Traumatology, Arthroscopy 7 (2012): 1216-1226.
12. Lonner JH. “Patellofemoral arthroplasty: pros, cons, and design considerations”. Clinical Orthopaedics and Related Research 428 (2004): 158-165.
13.  Gupta RR., et al. “Scientific evidence for the use of modern patellofemoral arthroplasty”. Expert Review of Medical Devices 7.1 (2010): 51-66.
14. Lustig S. “Patellofemoral arthroplasty”. Orthopaedics and Traumatology: Surgery and Research 1 (2015): S35-43.
15. Rodriguez-Merchan EC. “Surgical treatment of isolated patellofemoral osteoarthritis”. HSS Journal1 (2014): 79-82.
16. Koh IJ., et al. “The Patient's Age and American Society of Anesthesiologists Status Are Reasonable Criteria for Deciding Whether to Perform Same-Day Bilateral TKA”. Journal of Arthroplasty5 (2015): 770-775.
17. Grelsamer RP., et al. “The pathophysiology of patellofemoral arthritis”. Orthopedic Clinics of North America 3 (2008): 269-274.
18. Lonner JH. “Patellofemoral arthroplasty”. Orthopedics9 (2010): 653.
19. Minkowitz RB and Bosco JA. “Patellofemoral arthritis”. Bulletin of the NYU Hospital for Joint Diseases 1 (2009): 30-38.
20. Willekens P., et al. “Outcome of patellofemoral arthroplasty, determinants for success”. Acta Orthopaedica Belgica 4 (2015): 759-767.

Citation

Citation: Luis Fernando Jordao Dos Santos. “Patellofemoral Arthroplasty: Early Demographic and Radiological Analysis for Less Complications and Better Results”.Acta Scientific Orthopaedics 5.12 (2022): 93-98.

Copyright

Copyright: © 2022 Luis Fernando Jordao Dos Santos. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.